The project on neuroblastoma led by Elisa Martí Gorostiza, a researcher at the Institute of Molecular Biology of Barcelona-CSIC and the Catalan Biotechnology Reference Network (XRB), has received one of the three grants for research projects on childhood cancer funded by the Spanish Association Against Cancer (AECC). The 150,000 € grant, obtained with the collaboration of the XRB, will be managed by the FBG. Neuroblastoma is the most common childhood cancer during the first year of infancy and presents a low cure rate (below 40%) in high-risk cases. It originates in the transient embryonic cells of the neural crest, and its clinical course is unique and enigmatic.
Further information here.
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Many repetitive regions of the genome have been considered “junk DNA...
Biotechnology portal in Spain
Subscribe to our newsletter and stay up to date with the latest news and deals!
2013 © Biotech-Spain.com - Site Developments SL. All Rights Reserved. Terms of Service | Privacy Policy
Articles
Directory
